Mean-Shine Chen

Title: Innovations of Mean-Shine Chen

Introduction

Mean-Shine Chen is a notable inventor based in Jhongli, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of viral constructs for vaccine production and bio-insecticides. With a total of three patents to his name, Chen's work showcases his innovative approach to solving complex biological challenges.

Latest Patents

Chen's latest patents include a recombinant baculovirus vector and a hybrid baculovirus. The recombinant baculovirus vector is designed to express three exogenous proteins simultaneously, including antigens for classical swine fever virus (CSFV) and porcine circovirus type 2 (PCV2), along with an immunomodulatory protein. This construct serves as a bio-tool for producing multiple antigens for a bi-subunit vaccine. His hybrid baculovirus patent involves an AcMNPV-based construct that can infect various hosts. This hybrid baculovirus incorporates genes from multiple nucleopolyhedroviruses, making it a promising bio-insecticide capable of delivering toxic protein genes to different insect hosts.

Career Highlights

Mean-Shine Chen is affiliated with Chung Yuan Christian University, where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in both vaccine development and pest control, highlighting his role as a key innovator in these fields.

Collaborations

Chen collaborates with esteemed colleagues such as Tzong-Yuan Wu and Chao-Yi Teng. Their combined expertise enhances the research output and innovation potential within their projects.

Conclusion

Mean-Shine Chen's contributions to biotechnology through his patents reflect his commitment to innovation and problem-solving in the field. His work not only advances scientific knowledge but also has practical implications for public health and agriculture.